<DOC>
	<DOCNO>NCT00724373</DOCNO>
	<brief_summary>The study design retrospective data review medical record participant select specialist secondary tertiary care center across United Kingdom ( UK ) , specialize Hepatitis C treatment . The study non-interventional design identify subgroup Hepatitis C Virus ( HCV ) genotype 1 participant 'real world ' , include relation subgroup characteristic treatment responsiveness .</brief_summary>
	<brief_title>Study HCV Genotype 1 Patients UK Treated With ViraferonPeg Rebetol ( Study P05269 ) ( COMPLETED )</brief_title>
	<detailed_description>Physicians record information ( time first exposure pegylated interferon alfa-2b ribavirin ) medical note participant fit inclusion criterion . To prevent selection bias , data take late consecutive , unique participant see physician previous 48 month . This provide method random sample physician practice .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Participants genotype 1 HCV infection treat pegylated interferon alfa2b ribavirin precede 48 month include . They divide : Completer participant : Patients diagnosis HCV genotype 1 complete course interferon alfa2b ribavirin , prior treatment HCV ( ie , previously treatment na√Øve ) . Completer participant must least 24 week follow data available post completion treatment ensure ability ass SVR rate . Early terminator : Participants terminate treatment early due adverse event reason ( ie , exposure incomplete ) . Participants currently undergo therapy therefore terminate treatment , ie , exposure still ongoing . Coinfected HCV participant ( eg , human immunodeficiency virus [ HIV ] hepatitis B virus [ HBV ] ) . Participants receive first HCV treatment relation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>